法國一嬰兒因維生素D補充劑死亡
France has acted to suspend the sale of a vitamin D supplement after the death of a newborn baby who suffocated hours after being given it.
近日，因發生嬰兒在攝入維生素D補充劑幾小時後死亡，法國目前已經暫停其銷售。The 10-day-old baby had been given a dose of Uvesterol D, widely given to French children under the age of five to prevent vitamin D deficiency.
這個出生10天的嬰兒服用的是一定劑量的Uvesterol D，該藥物被廣泛應用於法國5歲以下的兒童，以預防維生素D缺乏。France's medical safety agency said there was a "probable link" to that particular supplement.
據法國的醫療安全機構表示，死亡“可能”和該補充劑“有關”。
Health Minister Marisol Touraine said children were not in danger by taking vitamin D supplements in general as "it's the specific way the product is administered that poses risks". She promised parents "transparent, objective and reliable information."
衛生部長瑪麗索爾·杜函娜表示，一般來說，兒童攝入合適量的維生素D並不會有任何危險，他們懷疑可能是通過吸管補充維生素D的方式構成了危險。她向嬰兒的父母承諾，會提供“透明、客觀和可靠的信息”。
News of the baby's death was not disclosed by France's health authorities immediately but emerged in French media.
該嬰兒死亡的消息並沒有及時被法國衛生當局披露，而是由法國媒體曝光的。ANSM said that in 2006 it had imposed measures to reduce risks from taking Uvesterol D after adverse effects became known. However, until December there had been no deaths since it went on the market in 1990, it added.
法國衛生局稱，在得知Uvesterol D的副作用後，他們已於2006年採取措施減少其風險。然而，直到去年十二月，自1990年上市以來，該藥物沒有致死案例。In 2013, the medical safety agency urged parents to give the supplement drip-by-drip before feeding and ensure the baby was in a semi-sitting position. It also reduced the recommended dosage.
在2013年，醫療安全機構督促父母在使用滴管喂兒童時要確保兒童處於半坐姿，而且需要減少推薦劑量。In 2014, health journal Prescire called for an end to the use of Uvesterol vitamin supplements for newborn babies, complaining of half-measures and procrastination from both the company and the medical safety agency.
2014年，健康雜誌《Prescire》呼籲停止讓新生兒服用Uvesterol維生素補充劑，並指責該醫藥廠商和醫療安全機構沒有給予足夠措施並拖延解決問題。
